Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
F:FDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
F:FDY
|
CN |
|
M
|
Marston's PLC
F:WVDA
|
UK |
|
Eiger BioPharmaceuticals Inc
F:72C1
|
US |
|
Semac Consultants Ltd
BSE:505368
|
IN |
|
S
|
Structural Monitoring Systems PLC
F:RJP
|
AU |
|
GNI Group Ltd
F:3G6
|
JP |
|
R
|
Ross Group PLC
F:8SS
|
UK |
|
Kooth PLC
F:KO0
|
UK |
|
N
|
Nevada Exploration Inc
F:28N
|
CA |
|
M
|
Matsui Securities Co Ltd
XMUN:MTW
|
JP |
Bankruptcy Probability
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
|
1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
657.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
386.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
243.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
285.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd has total debt of 7.9m CNY. This includes both short-term (0 CNY) and long-term (7.9m CNY) debt.
You can find a full breakdown on its Balance Sheet.
